{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:25:19Z","timestamp":1778826319644,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5P30 DA01104123"],"award-info":[{"award-number":["5P30 DA01104123"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007233"],"award-info":[{"award-number":["T32DA007233"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jsat.2021.108371","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T07:48:10Z","timestamp":1616053690000},"page":"108371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention"],"prefix":"10.1016","volume":"129","author":[{"given":"J.","family":"Jaiswal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.N.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hascher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"LoSchiavo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108371_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-013-0593-y","article-title":"Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review","author":"Abdul-Quader","year":"2013","journal-title":"AIDS and Behavior."},{"key":"10.1016\/j.jsat.2021.108371_bb0015","article-title":"HIV providers\u2019 likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report","author":"Adams","year":"2016","journal-title":"AIDS Care - Psychological and Socio-Medical Aspects of AIDS\/HIV."},{"issue":"151","key":"10.1016\/j.jsat.2021.108371_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men","volume":"4","author":"Anderson","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"12","key":"10.1016\/j.jsat.2021.108371_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/apc.2018.0126","article-title":"Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs","volume":"32","author":"Bazzi","year":"2018","journal-title":"AIDS Patient Care and STDs"},{"key":"10.1016\/j.jsat.2021.108371_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2017-053377","article-title":"Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California","author":"Beymer","year":"2018","journal-title":"Sexually Transmitted Infections."},{"key":"10.1016\/j.jsat.2021.108371_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s13178-018-0366-5","article-title":"Transactional sex, substance use, and sexual risk: Comparing pay direction for an internet-based U.S. sample of men who have sex with men","author":"Bond","year":"2019","journal-title":"Sexuality Research and Social Policy"},{"key":"10.1016\/j.jsat.2021.108371_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s10900-016-0234-2","article-title":"Exchange of sex for drugs or money in adolescents and young adults: An examination of sociodemographic factors, hiv-related risk, and community context","author":"Boyer","year":"2017","journal-title":"Journal of Community Health"},{"key":"10.1016\/j.jsat.2021.108371_bb0050","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2017.304061","article-title":"Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities","author":"Calabrese","year":"2017","journal-title":"American Journal of Public Health."},{"key":"10.1016\/j.jsat.2021.108371_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157324","article-title":"Putting PrEP into practice: Lessons learned from early-adopting U.S. providers\u2019 firsthand experiences providing HIV pre-exposure prophylaxis and associated care","author":"Calabrese","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jsat.2021.108371_bb0060","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S2352-3018(19)30030-X","article-title":"Providers should discuss U= U with all patients living with HIV","volume":"6","author":"Calabrese","year":"2019","journal-title":"The Lancet HIV"},{"issue":"10","key":"10.1016\/j.jsat.2021.108371_bb0065","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2105\/AJPH.2015.302816","article-title":"How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize \u201cTruvada whores\u201d","volume":"105","author":"Calabrese","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108371_bb0080","series-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States - 2014: A clinical practice guideline","author":"CDC Center for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.jsat.2021.108371_bb0085","author":"CDC Center for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2021.108371_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-13-53","article-title":"High coverage needle\/syringe programs for people who inject drugs in low and middle income countries: A systematic review","author":"Des Jarlais","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jsat.2021.108371_bb0105","article-title":"HIV infection among persons who inject drugs: Ending old epidemics and addressing new outbreaks","author":"Des Jarlais","year":"2016","journal-title":"AIDS."},{"issue":"5","key":"10.1016\/j.jsat.2021.108371_bb0110","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s10461-017-1690-0","article-title":"Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men","volume":"21","author":"Eaton","year":"2017","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2021.108371_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-016-1612-6","article-title":"Primary care Physicians\u2019 willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs","author":"Edelman","year":"2017","journal-title":"AIDS and Behavior."},{"key":"10.1016\/j.jsat.2021.108371_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/10550887.2014.975612","article-title":"Formal and informal organizational activities of people who inject drugs in New York City: Description and correlates","author":"Friedman","year":"2015","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1016\/j.jsat.2021.108371_bb0125","first-page":"7","article-title":"Pre-exposure prophylaxis for HIV prevention in those with substance use disorders","volume":"8","author":"Goldstein","year":"2018","journal-title":"Manager\u2019s Journal on Nursing"},{"key":"10.1016\/j.jsat.2021.108371_bb0130","doi-asserted-by":"crossref","DOI":"10.1007\/s11904-018-0385-0","article-title":"PrEP stigma: Implicit and explicit drivers of disparity","author":"Golub","year":"2018","journal-title":"Current HIV\/AIDS Reports"},{"key":"10.1016\/j.jsat.2021.108371_bb0135","article-title":"Establishing trustworthiness","author":"Guba","year":"1985","journal-title":"Naturalistic Inquiry."},{"issue":"4","key":"10.1016\/j.jsat.2021.108371_bb0140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.13437","article-title":"\u201cPrEP is not ready for our community, and our community is not ready for PrEP\u201d: Pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response","volume":"112","author":"Guise","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2021.108371_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1570162X16666180730144455","article-title":"Structural barriers to pre-exposure prophylaxis use among young sexual minority men: The P18 cohort study","volume":"16","author":"Jaiswal","year":"2018","journal-title":"Current HIV Research"},{"key":"10.1016\/j.jsat.2021.108371_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2014.10.015","article-title":"Differences in HIV risk behaviors among people who inject drugs by gender and sexual orientation, San Francisco, 2012","author":"Jin","year":"2014","journal-title":"Drug and Alcohol Dependence."},{"key":"10.1016\/j.jsat.2021.108371_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-014-0839-3","article-title":"HIV providers\u2019 perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study","author":"Krakower","year":"2014","journal-title":"AIDS and Behavior."},{"key":"10.1016\/j.jsat.2021.108371_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132398","article-title":"Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: Results from a survey of healthcare providers in New England","author":"Krakower","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2021.108371_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2016.10.017","article-title":"Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs","author":"Lake","year":"2016","journal-title":"Drug and Alcohol Dependence."},{"key":"10.1016\/j.jsat.2021.108371_bb0185","doi-asserted-by":"crossref","unstructured":"Mayer, K. H., Chan, P. A., R Patel, R., Flash, C. A., & Krakower, D. S. (2018). Evolving models and ongoing challenges for HIV Preexposure prophylaxis implementation in the United States. Journal of Acquired Immune Deficiency Syndromes (1999). doi:https:\/\/doi.org\/10.1097\/QAI.0000000000001579.","DOI":"10.1097\/QAI.0000000000001579"},{"key":"10.1016\/j.jsat.2021.108371_bb0190","first-page":"1","article-title":"Are sexual minority stressors associated with young men who have sex with men\u2019s (YMSM) level of engagement in PrEP?","author":"Meanley","year":"2020","journal-title":"Behavioral Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2021.108371_bb5000","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy097","article-title":"Redefining prevention and care: A status-neutral approach to HIV","volume":"5","author":"Myers","year":"2018","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.jsat.2021.108371_bb0205","doi-asserted-by":"crossref","DOI":"10.1080\/19419899.2018.1425220","article-title":"A comparison of self-reported sexual effects of alcohol, marijuana, and ecstasy in a sample of young adult nightlife attendees","author":"Palamar","year":"2018","journal-title":"Psychology and Sexuality."},{"key":"10.1016\/j.jsat.2021.108371_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30292-3","article-title":"Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs","author":"Reddon","year":"2019","journal-title":"The Lancet HIV."},{"key":"10.1016\/j.jsat.2021.108371_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2015.12.018","article-title":"United States family planning providers\u2019 knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: A national survey","author":"Seidman","year":"2016","journal-title":"Contraception."},{"key":"10.1016\/j.jsat.2021.108371_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00561","article-title":"Developing an integrated, brief biobehavioral HIV prevention intervention for high-risk drug users in treatment: The process and outcome of formative research","author":"Shrestha","year":"2017","journal-title":"Frontiers in Immunology."},{"key":"10.1016\/j.jsat.2021.108371_bb0230","first-page":"1","article-title":"Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: A pilot feasibility study","author":"Shrestha","year":"2018","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2021.108371_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fpubh.2018.00195","article-title":"Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment","volume":"6","author":"Shrestha","year":"2018","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.jsat.2021.108371_bb0240","doi-asserted-by":"crossref","first-page":"108058","DOI":"10.1016\/j.jsat.2020.108058","article-title":"Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs","volume":"117","author":"Shrestha","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108371_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2016.12.023","article-title":"Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment","author":"Shrestha","year":"2017","journal-title":"Drug and Alcohol Dependence."},{"key":"10.1016\/j.jsat.2021.108371_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156592","article-title":"PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009-2015","author":"Smith","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2021.108371_bb0255","article-title":"PrEP in substance abuse treatment: A qualitative study of treatment provider perspectives","author":"Spector","year":"2015","journal-title":"Substance Abuse: Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2021.108371_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","author":"Uhlmann","year":"2010","journal-title":"Addiction."},{"key":"10.1016\/j.jsat.2021.108371_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102934","article-title":"Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. northeast","volume":"85","author":"Valente","year":"2020","journal-title":"The International journal on Drug Policy"},{"key":"10.1016\/j.jsat.2021.108371_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-018-2039-z","article-title":"Exchange sex among persons who inject drugs in the New York metropolitan area: The importance of local context, gender and sexual identity","author":"Walters","year":"2018","journal-title":"AIDS and Behavior"},{"issue":"12","key":"10.1016\/j.jsat.2021.108371_bb0280","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/apc.2019.0119","article-title":"HIV pre-exposure prophylaxis implementation Cascade among health care professionals in the United States: Implications from a systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2019","journal-title":"AIDS Patient Care and STDs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:38Z","timestamp":1760039618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":44,"alternative-id":["S0740547221000970"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108371","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108371"}}